These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Mastocytosis--diagnostic criteria and treatment]. Dereń-Wagemann I; Kuliszkiewicz-Janus M; Kuliczkowski K Postepy Hig Med Dosw (Online); 2009 Nov; 63():564-76. PubMed ID: 20009120 [TBL] [Abstract][Full Text] [Related]
10. Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis. Pardanani A; Chen D; Abdelrahman RA; Reichard KK; Zblewski D; Wood AJ; McClure RF; Butterfield JH; Hanson CA; Tefferi A Leukemia; 2013 Oct; 27(10):2091-4. PubMed ID: 23896642 [No Abstract] [Full Text] [Related]
11. Mastocytosis: current concepts in diagnosis and treatment. Escribano L; Akin C; Castells M; Orfao A; Metcalfe DD Ann Hematol; 2002 Dec; 81(12):677-90. PubMed ID: 12483363 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis, progression patterns and prognostication in mastocytosis. Sperr WR; Valent P Expert Rev Hematol; 2012 Jun; 5(3):261-74. PubMed ID: 22780207 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients. Sánchez-Muñoz L; Morgado JM; Álvarez-Twose I; Matito A; Garcia-Montero AC; Teodosio C; Jara-Acevedo M; Mayado A; Mollejo M; Caldas C; González de Olano D; Escribano L; Orfao A Br J Haematol; 2016 Jan; 172(1):56-63. PubMed ID: 26456532 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Orfao A; Garcia-Montero AC; Sanchez L; Escribano L; Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis]. Sotlar K Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612 [TBL] [Abstract][Full Text] [Related]
16. [Mastocytosis: when should it be considered?]. Comte-Perret S; Bart PA; Spertini F; Leimgruber A Rev Med Suisse; 2009 Apr; 5(199):837-42. PubMed ID: 19441750 [TBL] [Abstract][Full Text] [Related]
17. World Health Organization Classification and Diagnosis of Mastocytosis: Update 2023 and Future Perspectives. Valent P; Sotlar K; Horny HP; Arock M; Akin C Immunol Allergy Clin North Am; 2023 Nov; 43(4):627-649. PubMed ID: 37758403 [TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA). Escribano L; Diaz-Agustin B; López A; Núñez López R; García-Montero A; Almeida J; Prados A; Angulo M; Herrero S; Orfao A; Cytometry B Clin Cytom; 2004 Mar; 58(1):1-8. PubMed ID: 14994369 [TBL] [Abstract][Full Text] [Related]
19. [Molecular pathological analysis of neoplastic mast cells with regard to the actual WHO classification of mast cell neoplasias]. Sotlar K Verh Dtsch Ges Pathol; 2006; 90():227-35. PubMed ID: 17867601 [TBL] [Abstract][Full Text] [Related]